Navigation Links
Shire and Boston Children's Hospital Enter Into Broad Research Collaboration
Date:11/20/2012

hire HGT. "Shire has a deep commitment to patients with rare diseases, and our developmental expertise combined with Boston Children's research capabilities should enable an acceleration of our discovery and development efforts. Our collaboration with Boston Children's is an ideal example of how we advance these goals."

"We are excited about the potential that the collaboration with Shire represents," said Dr. Alan Beggs, Director of the Manton Center for Orphan Disease Research at Boston Children's. "Boston Children's brings the research infrastructure to make the foundational discoveries about these diseases and our clinicians know the patients and their needs. Partnering with Shire's drug development capabilities represents a powerful combination that we hope will facilitate the development of new classes of therapy to ultimately benefit patients."

Notes to editors

Shire enables people with life-altering conditions to lead better lives.

Through our deep understanding of patients' needs, we develop and provide healthcare in the areas of:

  • Behavioral Health and Gastro Intestinal conditions
  • Rare Diseases
  • Regenerative Medicine

as well as other symptomatic conditions treated by specialist physicians.

We aspire to imagine and lead the future of healthcare, creating value for patients, physicians, policymakers, payors and our shareholders.

About Boston Children's Hospital

Founded in 1869 as a 20-bed hospital for children, Boston Children's Hospital has been ranked as one of the nation's best pediatric hospitals by U.S.News & World Report for the past 21 years. Boston Children's is the primary pediatric teaching hospital of Harvard Medical School and the largest provider of health care to Massachusetts children. In addition to 396 pediatric and adolescent inpatient beds and 228 outpatient programs, Boston Children's houses the world's large
'/>"/>

SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
2. Shire Changes its NASDAQ Ticker Symbol to SHPG
3. Berkshire Corporation Offers Live Chat For Americas Website and Shopping Cart
4. Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th
5. Shire plc: First Quarter 2012 Results Date Notification - April 26, 2012
6. Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders
7. Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
8. Boston Childrens Hospital announces international genomics competition winner
9. BioBDx to Present at the 2012 BioPharm America and AdvaMed MedTech Conferences in Boston
10. Alacrita Establishes U.S. Headquarters in Boston Area
11. Sanofi Signs Agreement for Type 1 Diabetes Research with Boston Academic Teaching Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... DUBLIN , June 02, 2015 Research ... the "Genotyping Market by Technology, Application & by ... their offering. The global genotyping market is ... Billion in 2015, at a CAGR of 22.3% during ... Market growth will be attributed to the availability of ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 “Stem Cell Therapy ... more mainstream, and it is used often as an adjunct ... general practitioners are not yet aware or comfortable enough with ... therapy is most often reserved for the last resort cases ... pet can barely lift a paw to get around. It ...
(Date:6/2/2015)... , June 2, 2015  RXi ... biotechnology company focused on discovering and developing ... dermatology and ophthalmology, today announced that Dr. ... will present at the 23 rd ... world congress will include in-depth presentations by ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Through rare ... technology, Yancy Corporation is enabling World Scientists ... material and biological sample, displaying the full nature (position, ... between atoms. , Jeff Porter, Co-Founder of the Yancy ... just that – rare. They come once in a ...
Breaking Biology Technology:Genotyping Market Report 2015 by Technology, Application & by Products - Global Forecast to 2020 for the $17 Billion Market 2VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities. 2VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities. 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 4Scientists Eying Rare Discovery Of New Physics & Light Microscope Technology 2
... Carolina, July 26, 2011 ... research organisation (CRO) with a trusted process for ... Swiss-based global biopharmaceutical group with a focus on ... strategic partnership. Under the terms of the agreement, ...
... CLINTON TOWNSHIP, Mich., July 25, 2011 Robert Ettinger, the ... died on Saturday, July 23, at home in Clinton Township, ... movement advocates storage at very low temperatures after death in ... cure of aging and disease. Mr. Ettinger ...
... 2011 BioDelivery Sciences International, Inc. (Nasdaq: ... completed the randomized portion of its Phase 3 clinical ... for the treatment of moderate to severe chronic pain, ... "We are very pleased to have brought ...
Cached Biology Technology:INC Research and Debiopharm Group(TM) Announce Strategic Partnership 2INC Research and Debiopharm Group(TM) Announce Strategic Partnership 3Founder of Cryonics Movement Dies, is Frozen at Cryonics Institute 2BioDelivery Sciences Announces Completion of BEMA Buprenorphine Phase 3 Chronic Pain Study 2BioDelivery Sciences Announces Completion of BEMA Buprenorphine Phase 3 Chronic Pain Study 3
(Date:5/6/2015)... 6, 2015 LifeBEAM, a developer of bio-sensing ... announced today that they will expand their partnership in ... bio-sensing cycling helmet and the first joint project between ... colors in order to give cyclists more style choices ... LifeBEAM and Lazer announced their plan to release a ...
(Date:4/21/2015)... , April 21, 2015 ... government policies are boosting access control systems market in ... According to a recently published report by TechSci Research ... ", the access control systems market in ... billion by 2020.The access control systems market in the ...
(Date:4/14/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... New York Design Awards under the category  ,Product Design ... Design Awards are part of a global multi-disciplinary awards ... from the marketplace, industry and judging panel. Winners will ...
Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
... R. LeDuc will join more than 70 of the ... Keck Futures Initiative on Complexity at the Beckman Conference ... discuss the topic of complexity in areas spanning everything ... sustainable future. , "This is a great opportunity ...
... LANSING, Mich. Cholesterol crystals released in the bloodstream ... linings much further away from the site of the ... George Abela, a physician in Michigan State University,s ... of Medicine,s cardiology section, is leading innovative research into ...
... more induced abortions have a reduced risk of pre-eclampsia by ... physical activity during pregnancy protects against pre-eclampsia, compared to previous ... Norwegian Institute of Public Health (NIPH) that use data from ... The new results from MoBa were presented on Friday 7th ...
Cached Biology News:Carnegie Mellon's Philip LeDuc participates in think tank forums 2Previous abortions and exercise: Do they affect pregnancy? 2Previous abortions and exercise: Do they affect pregnancy? 3
Mouse VEGF R1/Flt-1 Phycoerythrin MAb (Clone 141522) Keywords: Receptor Tyrosine Kinase, RTK, VEGFR1, VEGF Receptor 1 Protein Family: Receptor Tyrosine Kinases, VEGF/PDGF Family...
Affinity Purified Anti-Human NP-1...
Mouse Anti-Amyloid beta [1-16], clone 6E10, Monoclonal Antibody...
HES-1 [Hairy 1], Available Summer 2003...
Biology Products: